Meske DS - Search Results

1

Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.

Campbell JN, Stevens R, Hanson P, Connolly J, Meske DS, Chung MK, Lascelles BDX. Campbell JN, et al. Among authors: meske ds. Molecules. 2021 Feb 3;26(4):778. doi: 10.3390/molecules26040778. Molecules. 2021. PMID: 33546181 Free PMC article. Review.

2

Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone.

Markman J, Meske DS, Kopecky EA, Vaughn B, O'Connor ML, Passik SD. Markman J, et al. Among authors: meske ds. J Pain Res. 2018 Sep 26;11:2051-2059. doi: 10.2147/JPR.S168836. eCollection 2018. J Pain Res. 2018. PMID: 30288095 Free PMC article.

3

Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic Pain.

Meske DS, Vaughn BJ, Kopecky EA, Katz N. Meske DS, et al. J Pain Res. 2019 Nov 20;12:3161-3165. doi: 10.2147/JPR.S201751. eCollection 2019. J Pain Res. 2019. PMID: 31819600 Free PMC article.

4

Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER).

Meske D, Kopecky EA, Passik S, Shram MJ. Meske D, et al. J Opioid Manag. 2018 Sep/Oct;14(5):359-372. doi: 10.5055/jom.2018.0468. J Opioid Manag. 2018. PMID: 30387859 Clinical Trial.

5

Tapentadol is the least common opioid found in admission urine drug-test results at an intensive outpatient opioid-use disorder treat-ment program in Ohio: A brief report.

Rzetelny A, Meske D, Patel P, Passik S. Rzetelny A, et al. J Opioid Manag. 2021 Jan-Feb;17(1):13-17. doi: 10.5055/jom.2021.0610. J Opioid Manag. 2021. PMID: 33735424

6

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials.

Meske DS, Lawal OD, Elder H, Langberg V, Paillard F, Katz N. Meske DS, et al. J Pain Res. 2018 May 3;11:923-934. doi: 10.2147/JPR.S160255. eCollection 2018. J Pain Res. 2018. PMID: 29765246 Free PMC article.

7

Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set.

Singla NK, Meske DS, Desjardins PJ. Singla NK, et al. Among authors: meske ds. Pain Ther. 2017 Dec;6(2):165-175. doi: 10.1007/s40122-017-0074-5. Epub 2017 Jul 4. Pain Ther. 2017. PMID: 28676997 Free PMC article. Review.

8

Erratum to: Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set.

Singla NK, Meske DS, Desjardins PJ. Singla NK, et al. Among authors: meske ds. Pain Ther. 2017 Dec;6(2):177-178. doi: 10.1007/s40122-017-0078-1. Pain Ther. 2017. PMID: 28853028 Free PMC article. No abstract available.

9

Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion events.

Jones T, Moore TM, Meske DS, Passik SD. Jones T, et al. Among authors: meske ds. J Opioid Manag. 2023 Jan-Feb;19(1):35-42. doi: 10.5055/jom.2023.0757. J Opioid Manag. 2023. PMID: 36683299

10

Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.

Meske DS, Xie JY, Oyarzo J, Badghisi H, Ossipov MH, Porreca F. Meske DS, et al. Neurosci Lett. 2014 Mar 6;562:91-6. doi: 10.1016/j.neulet.2013.08.017. Epub 2013 Aug 19. Neurosci Lett. 2014. PMID: 23969300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page